1. Home
  2. SY vs ABEO Comparison

SY vs ABEO Comparison

Compare SY & ABEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo So-Young International Inc. American Depository Shares

SY

So-Young International Inc. American Depository Shares

HOLD

Current Price

$3.15

Market Cap

323.8M

Sector

Technology

ML Signal

HOLD

Logo Abeona Therapeutics Inc.

ABEO

Abeona Therapeutics Inc.

HOLD

Current Price

$4.55

Market Cap

280.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SY
ABEO
Founded
2013
1974
Country
China
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
323.8M
280.2M
IPO Year
2018
2005

Fundamental Metrics

Financial Performance
Metric
SY
ABEO
Price
$3.15
$4.55
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
4
Target Price
$5.50
$18.75
AVG Volume (30 Days)
340.6K
1.1M
Earning Date
01-01-0001
07-02-2026
Dividend Yield
0.79%
N/A
EPS Growth
N/A
165.16
EPS
N/A
1.01
Revenue
N/A
$2,998,000.00
Revenue This Year
$6.36
N/A
Revenue Next Year
$57.24
$1,589.77
P/E Ratio
N/A
$4.73
Revenue Growth
N/A
258.18
52 Week Low
$0.67
$3.93
52 Week High
$6.28
$7.54

Technical Indicators

Market Signals
Indicator
SY
ABEO
Relative Strength Index (RSI) 51.74 36.43
Support Level $2.80 $4.53
Resistance Level $3.33 $5.62
Average True Range (ATR) 0.17 0.21
MACD 0.01 -0.04
Stochastic Oscillator 63.33 21.69

Price Performance

Historical Comparison
SY
ABEO

About SY So-Young International Inc. American Depository Shares

So-Young International Inc is an online destination for discovering, evaluating, and reserving medical aesthetic services in China. Its business model comprises four integrated components: professional content and its distribution through social media networks and its targeted media platforms in China, a social community characterized by signature user-generated content, Online reservation services for a medical aesthetic treatment, and the research, development, production, sales and agency of laser and other optoelectronic medical beauty equipment. It generates revenue from information services fees and reservation services fees from medical aesthetic service providers.

About ABEO Abeona Therapeutics Inc.

Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.

Share on Social Networks: